Hao Q L, Shah A J, Thiemann F T, Smogorzewska E M, Crooks G M
Division of Research Immunology and Bone Marrow Transplantation, Childrens Hospital Los Angeles, CA 90027, USA.
Blood. 1995 Nov 15;86(10):3745-53.
We present cell cycling and functional evidence that the CD34+CD38- immunophenotype can be used to define a rare and primitive subpopulation of progenitor cells in umbilical cord blood. CD34+CD38- cells comprise 0.05% +/- 0.08% of the mononuclear cells present in cord blood. Cell cycle analysis with the fluorescent DNA stain 7-aminoactinomycin D showed that the percentage of CD34+ cells in cycle directly correlated with increasing CD38 expression. CD34+CD38- cord blood cells were enriched for long-term culture-initiating cells (LTCIC; cells able to generate colony-forming unit-cells [CFU-C] after 35 to 60 days of coculture with bone marrow stroma) relative to CD34+CD38- cells. In an extended LTCIC assay, CD34+CD38- cells were able to generate CFU-C between days 60 and 100, clearly distinguishing them from CD34+CD38+ cells that did not generate CFU-C beyond day 40. When plated as single cells, onset of clonal proliferation was markedly delayed in a subpopulation of CD34+CD38- cells; clones (defined as > 100 cells) appeared after 60 days of culture in 2.9% of CD34+CD38- cells. In contrast, 100% of CD34+CD38+ cells formed clones by day 21. Although the CD34+CD38- immunophenotype defines highly primitive populations in both bone marrow and cord blood, important functional differences exist between the two sources. CD34+CD38- cord blood cells have a higher cloning efficiency, proliferate more rapidly in response to cytokine stimulation, and generate approximately sevenfold more progeny than do their counterparts in bone marrow.
我们提供了细胞周期和功能方面的证据,表明CD34+CD38-免疫表型可用于定义脐带血中罕见且原始的祖细胞亚群。CD34+CD38-细胞占脐带血中单核细胞的0.05%±0.08%。用荧光DNA染料7-氨基放线菌素D进行细胞周期分析表明,处于细胞周期中的CD34+细胞百分比与CD38表达的增加直接相关。相对于CD34+CD38+细胞,CD34+CD38-脐带血细胞富含长期培养起始细胞(LTCIC;与骨髓基质共培养35至60天后能够产生集落形成单位细胞[CFU-C]的细胞)。在扩展的LTCIC测定中,CD34+CD38-细胞能够在第60天至第100天之间产生CFU-C,这明显将它们与在第40天之后不再产生CFU-C的CD34+CD38+细胞区分开来。当以单细胞接种时,CD34+CD38-细胞亚群的克隆增殖起始明显延迟;在2.9%的CD34+CD38-细胞中,培养60天后出现克隆(定义为>100个细胞)。相比之下,100%的CD34+CD38+细胞在第21天形成克隆。尽管CD34+CD38-免疫表型在骨髓和脐带血中都定义了高度原始的群体,但这两种来源之间存在重要的功能差异。CD34+CD38-脐带血细胞具有更高的克隆效率,对细胞因子刺激的增殖更快,并且产生的后代比骨髓中的对应细胞多约七倍。